MDGL vs SO · rev $180.1M vs P/E 22, rev $29.55B
Madrigal Pharmaceuticals Inc (MDGL) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported MDGL revenue for 2024-12-31 was $180.1M. Net income was -$465.9M. MDGL currently screens at market cap $11.56B.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
MDGL currently screens at market cap $11.56B. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the MDGL and SO stock pages for the full models.
Not investment advice.